Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The REMAIN-1 Pivotal Cohort has completed enrollment, and the Company remains on track to randomize patients in early 2026 and deliver 6-month topline primary endpoint data and potentially file a PMA in H2 2026
Flat-bottom 96-well plates were coated with anti-CD3 antibody (OKT3, Invitrogen, 14-0037-82) at two suboptimal concentrations (0.05 g ml 1 and 0.2 g ml 1 )
Nanobody therapies, including sonelokimab, showing superior skin penetration and robust PASI responses in phase 2 trials
Glutathione functions as a vital antioxidant compound in cellular environments
Remain inquisitive and continue to discover what suits you
It absorbs quickly into my skin and leaves a healthy and radiant glow
US$ 25.17
US$ 27.25
US$ 26.95
US$ 23.65
US$ 24.94
US$ 29.79
US$ 28.34
